CORE--CELL CULTURE, LP PREP AND CHARACTERIZATION
核心——细胞培养、LP 制备和表征
基本信息
- 批准号:6577282
- 负责人:
- 金额:$ 13.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by the applicant):
The primary function of this core is to provide all investigators of the SCOR
with defined cell cultures, lipoproteins, and lipoprotein analysis. The cell
culture core was established over 20 years ago and has been directed by Dr.
Quehenberger since 1995. Over the years it has proved its value to each unit
of the SCOR and has seen considerable expansion. With the demand for
lipoproteins and analytical procedures for lipoproteins considerably rising,
we decided to include these services into this core. The preparation of
lipoproteins by trained personnel within one designated facility ensures
preservation of quality. Moreover, the coordinate production based on demands
is cost-effective and guarantees a continuous supply.
Cell culture facility: This facility will provide all units with defined
cells, all necessary cell culture supplies, equipment and culture techniques.
The cell culture facility will facilitate the purchase and maintenance of
established cell lines and will supply the investigators with cells with
defined growth characteristics. On average, 10 different cell lines are
growing at any given time. Cells are generally maintained in minimum
quantities and are expanded only upon request. This prevents culturing of the
same cell lines in the various units at the same time and helps keeping tissue
culture costs at a minimum.
The cell culture core also assists in preparing and establishing transfected
cell lines. The participating investigators will supply the DNA constructs
and the transfections are then done as a service in the cell culture facility.
Various transfection reagents are being used depending on the cell type to be
transfected. Adherent cells are commonly transfected with liposome-based
reagents, while cells in suspension are usually electroporated. Screening and
purification of the transfectants will be provided. The investigators will be
responsible for the identification and confirmation of the clones. Transient
transfections are being carried out upon request.
Lipoprotein facility: This facility will provide the investigators of all
units with lipoprotein preparations and will carry out all plasma lipid
analyses. Lipoproteins (all classes) will be prepared on a biweekly basis or
upon request. Healthy volunteers will be recruited and blood samples (50 -200
ml) will be drawn in the Lipid Research Clinic at UCSD by specially
trained personnel under the supervision of Dr. Witztum. Lipoproteins will be
prepared by density gradient centrifugation following standard protocols. The
core facility will also provide lipoproteins including methylated, acetylated
and oxidized lipoproteins as well as lipoprotein-deficient sera. The core
facility also isolates and provides LDL from cholesterol-fed LDL receptor-deficient
mice as well as guinea pigs. Core facility personnel will also
prepare lipoproteins labeled with radionucleotides and fluorescent dyes.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OSWALD QUEHENBERGER其他文献
OSWALD QUEHENBERGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OSWALD QUEHENBERGER', 18)}}的其他基金
Role of macrophage receptors in atherogenesis
巨噬细胞受体在动脉粥样硬化形成中的作用
- 批准号:
7004357 - 财政年份:2004
- 资助金额:
$ 13.89万 - 项目类别:
Core B-- Cell Culture and LP prep and characterozation
核心 B——细胞培养、LP 制备和表征
- 批准号:
7004364 - 财政年份:2004
- 资助金额:
$ 13.89万 - 项目类别:
ROLE OF MACROPHAGE MEMBRANE RECEPTORS IN ATHEROGENESIS
巨噬细胞膜受体在动脉粥样硬化形成中的作用
- 批准号:
6577276 - 财政年份:2002
- 资助金额:
$ 13.89万 - 项目类别:
MONOCYTE ACTIVATION THROUGH THE MCP1 RECEPTOR CCR2
通过 MCP1 受体 CCR2 激活单核细胞
- 批准号:
2810535 - 财政年份:1998
- 资助金额:
$ 13.89万 - 项目类别:
ROLE OF MACROPHAGE MEMBRANE RECEPTORS IN ATHEROGENESIS
巨噬细胞膜受体在动脉粥样硬化形成中的作用
- 批准号:
7551457 - 财政年份:
- 资助金额:
$ 13.89万 - 项目类别: